Compound ID | 359
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against pathogens causing hospital acquired infections |
| Description: | Third-generation cephalosporin |
| Institute where first reported: | Sanofi (Sanofi Aventis, France) |
| Year first mentioned: | 1986 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9578292 |